相关实验视频

Updated: Sep 19, 2025

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models

Published on: June 20, 2025

一个基于组合模型的元分析,对来自随机COPD试验的聚合和个体FEV1数据进行了分析

Liang Yang¹, Carolina Llanos-Paez¹, Shuying Yang²

¹Department of Pharmacy, Uppsala University, Uppsala, Sweden.

CPT: pharmacometrics & systems pharmacology

|June 19, 2025

概括

这项研究开发了用于慢性阻塞性肺病 (COPD) 试验的综合总和个体患者数据 (ADIPD) 模型. ADIPD模型提高了协变量估计和临床试验模拟准确度.

科学领域:

制药指标 (Pharmacometrics) 是一个指标.
临床试验分析
数据建模数据建模

背景情况:

基于模型的元分析整合了聚合数据 (AD),但缺乏个人层面的细节.
个体患者级数据 (IPD) 是有价值的,但通常很难获得.
组合建模提供了一种利用AD和IPD的方法.

研究的目的:

为慢性阻塞性肺病 (COPD) 临床试验建立一个结合的ADIPD模型,使用1秒内强迫呼气量 (FEV1) 作为终点.
探索估计研究间变异性 (ISV),个人间变异性 (IIV) 和聚合偏差的方法.
评估共变系对聚合偏差的影响.

主要方法:

开发了单独的AD和IPD模型,然后将它们结合成一个ADIPD模型.
在NONMEM中利用随机模拟和估计 (SSE) 来进行参数估计,优化ISV/IIV估计策略.
为了减轻聚合偏差,为lognormal IIV推导了近似的正常分布.

主要成果:

ADIPD模型成功地整合了23种COPD化合物的数据,包括基线FEV1,疾病进展,安慰剂效应和剂量反应关系.
确定了影响基线FEV1和疾病进展的关键共变量 (例如年龄,性别,疾病严重程度,吸烟状况).
与AD-only模型相比,在ADIPD模型中对协变系数进行了更精确的估计.

结论:

结合ADIPD建模为分析复杂的COPD临床试验数据提供了强大的框架.
这种方法提高了共变量效应估计的精度,并减少了聚合偏差.
ADIPD建模为优化临床试验设计和药物开发提供了更为明智的模拟.

关键词:

慢性慢性肺炎是一种慢性慢性肺炎,COPD是一种慢性肺炎.汇总的数据是汇总的数据.聚合偏差是一种聚合偏差.组合建模的组合建模.个人-患者数据数据.

更多相关视频

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice

Published on: January 16, 2015

相关概念视频

COPD: Management Using Bronchodilators and Corticosteroids

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...